Shima Espahbodi1, Paul Bassett2, Charlotte Cavill3, Mandy Freeth3, John Hole3, Raj Sengupta4. 1. Royal National Hospital for Rheumatic Diseases (RNHRD), Bath, UK. shimxi@yahoo.com. 2. StatsConsultancy Ltd., Buckinghamshire, UK. 3. Royal National Hospital for Rheumatic Diseases (RNHRD), Bath, UK. 4. Royal National Hospital for Rheumatic Diseases (RNHRD), Bath, and University of Bath, UK.
Abstract
OBJECTIVES: To determine factors associated with absenteeism, presenteeism, work productivity loss (WPL), and daily activity impairment in UK patients with AxSpA using standardised measures. METHODS: 490 patients with AxSpA completed (1) Work Productivity and Impairment questionnaire (WPAI), providing measures for absenteeism, presenteeism, WPL and daily activity impairment, and (2) BASDAI, BASFI, BASMI, Jenkins Sleep scale, Patient Global Assessment disease activity (PGA), back pain night and anytime, EQ-5D for mobility, self-care, daily activities, pain/discomfort, anxiety/depression, EQ-VAS Health State Today, FACIT fatigue, for health-related disease factors. Multivariate linear and logistic regression determined associations between WPAI measures and health-related factors. RESULTS: 301(61%) patients provided WPAI measurements, 76% were male, 87% HLA-B27+. Mean (SD) WPAI scores for absenteeism were 5.1%(19.2), presenteeism 22%(24.3), WPL 23.2%(25.7), activity impairment 34.8%(27.3). Absenteeism was associated with higher fatigue levels and more likely in patients with nrAxSpA. Presenteeism and WPL were both associated higher fatigue levels, BASDAI, and BASFI respectively. Daily activity impairment was associated with higher fatigue levels, BASFI, PGA, EQ-VAS, and smoking. CONCLUSIONS: Work productivity and impairment are associated with fatigue, disease activity, and functional ability in UK patients with AxSpA. The strong association of fatigue with all work measures as well as with daily activity impairment emphasises the need to better understand the impact of fatigue on patients' quality of life. Improving fatigue may help to optimise work status.
OBJECTIVES: To determine factors associated with absenteeism, presenteeism, work productivity loss (WPL), and daily activity impairment in UK patients with AxSpA using standardised measures. METHODS: 490 patients with AxSpA completed (1) Work Productivity and Impairment questionnaire (WPAI), providing measures for absenteeism, presenteeism, WPL and daily activity impairment, and (2) BASDAI, BASFI, BASMI, Jenkins Sleep scale, Patient Global Assessment disease activity (PGA), back pain night and anytime, EQ-5D for mobility, self-care, daily activities, pain/discomfort, anxiety/depression, EQ-VAS Health State Today, FACIT fatigue, for health-related disease factors. Multivariate linear and logistic regression determined associations between WPAI measures and health-related factors. RESULTS: 301(61%) patients provided WPAI measurements, 76% were male, 87% HLA-B27+. Mean (SD) WPAI scores for absenteeism were 5.1%(19.2), presenteeism 22%(24.3), WPL 23.2%(25.7), activity impairment 34.8%(27.3). Absenteeism was associated with higher fatigue levels and more likely in patients with nrAxSpA. Presenteeism and WPL were both associated higher fatigue levels, BASDAI, and BASFI respectively. Daily activity impairment was associated with higher fatigue levels, BASFI, PGA, EQ-VAS, and smoking. CONCLUSIONS: Work productivity and impairment are associated with fatigue, disease activity, and functional ability in UK patients with AxSpA. The strong association of fatigue with all work measures as well as with daily activity impairment emphasises the need to better understand the impact of fatigue on patients' quality of life. Improving fatigue may help to optimise work status.
Authors: Larry A Greenbaum; Christoph Licht; Vasileios Nikolaou; Imad Al-Dakkak; Janet Green; Christian Stefan Haas; Elena Román-Ortiz; Hae Il Cheong; Lisa Sartz; Rita Swinford; Ioannis Tomazos; Benjamin Miller; Spero Cataland Journal: Kidney Int Rep Date: 2020-05-19
Authors: U Kiltz; J Braun; A Becker; J-F Chenot; M Dreimann; L Hammel; A Heiligenhaus; K-G Hermann; R Klett; D Krause; K-F Kreitner; U Lange; A Lauterbach; W Mau; R Mössner; U Oberschelp; S Philipp; U Pleyer; M Rudwaleit; E Schneider; T L Schulte; J Sieper; A Stallmach; B Swoboda; M Winking Journal: Z Rheumatol Date: 2019-12 Impact factor: 1.372
Authors: Isabella Berardelli; Salvatore Sarubbi; Dorian A Lamis; Elena Rogante; Valeria Canzonetta; Andrea Negro; Martina Guglielmetti; Alice Sparagna; Valerio De Angelis; Denise Erbuto; Maurizio Pompili; Paolo Martelletti Journal: Int J Environ Res Public Health Date: 2019-09-10 Impact factor: 3.390
Authors: Yuxin Li; Bingmei Guo; Yongchao Wang; Xiaoyan Lv; Rong Li; Xiangyun Guan; Li Li; Junli Li; Yingjuan Cao Journal: Front Public Health Date: 2022-01-14
Authors: Leanne Hassett; Anne Tiedemann; Rana S Hinman; Maria Crotty; Tammy Hoffmann; Lisa Harvey; Nicholas F Taylor; Colin Greaves; Daniel Treacy; Matthew Jennings; Andrew Milat; Kim L Bennell; Kirsten Howard; Maayken van den Berg; Marina Pinheiro; Siobhan Wong; Catherine Kirkham; Elizabeth Ramsay; Sandra O'Rourke; Catherine Sherrington Journal: BMJ Open Date: 2020-11-03 Impact factor: 2.692